Core Viewpoint - A class action lawsuit has been filed against Red Cat Holdings, Inc. for allegedly making false statements regarding its production capacity and contract values, impacting investor confidence and stock prices [1][3][6]. Company Overview - Red Cat Holdings, Inc. operates in the drone industry, providing products such as the "Teal 2" drone designed for military operations [2]. Allegations of the Lawsuit - The lawsuit claims that Red Cat overstated the production capacity of its Salt Lake City facility and the value of its Short Range Reconnaissance Program contract [3]. - On July 27, 2023, Red Cat disclosed that its Salt Lake City facility could only produce 100 drones per month, with potential future capacity of 1,000 drones per month contingent on further investments [4]. - Following this announcement, Red Cat's stock price fell nearly 9% [4]. Financial Performance - On September 23, 2024, Red Cat reported a loss per share of $0.17 for Q1 fiscal year 2025, missing estimates by $0.09, and revenue of $2.8 million, missing estimates by $1.07 million [5]. - The company admitted that retooling its Salt Lake City facility and a pause in manufacturing impacted Teal 2 sales, leading to a stock price drop of over 25% [5]. Additional Allegations - On January 16, 2025, a report from Kerrisdale Capital claimed that the SRR contract was smaller and less favorable than previously indicated by management, leading to a stock price decline of more than 21% over two trading sessions [6].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In NET Power To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in NET Power between June 9, 2023 and March 7, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Faruqi & ...

华夏时报（www.chinatimes.net.cn）记者 吴敏 北京报道 当监管重锤与诉讼浪潮共振，董事会的座椅开始发烫。从边缘走向聚光灯下，董责险正在为上市公司治理写下新 的注脚。 此言不虚，上市公司金通灵、美尚生态就因连续多年财务造假，损害投资者合法权益，遭集体诉讼。金通灵案的 被告为上市公司及董监高、中介机构及相关责任人员等24名，美尚生态案的被告为实际控制人王迎燕、徐晶及相 关董监高、中介机构及相关责任人等共20名。 来自证监会的一组数据则显示，2024年，证监会查办证券期货违法案件739件，作出处罚决定592件，处罚责任主 体1327人（家）次，市场禁入118人；向公安机关移送涉嫌犯罪案件和线索178件，罚没款金额达153.42亿元。 在邱剑看来，近年来发生的一些经典案例也让上市公司意识到董责险的重要性，促使其积极投保。如瑞幸咖啡在 赴美上市前，投保了一份董责险保单，总保额达到2500万美元，折合近2亿元人民币，由8家中资保险公司共保。 2020年瑞幸造假事件曝出后，瑞幸咖啡向保险公司提起了理赔申请。最终该保单的裁决结果为共保赔付700万美 元，免赔300万美元。目前已经按保险合同和共保协议完成相 ...

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of all persons or entities who purchased the securities of Red Cat Holdings, Inc. (“Red Cat” or the “Company”) (NASDAQ: RCAT) between March 18, 2022 and January 15, 2025, both dates inclusive (the “Class Period”). The Complaint alleges that Defendants throughout the Class Period made false and/or misl ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Organon & Co. due to misleading statements regarding its capital allocation strategy, particularly concerning dividends and debt reduction, which led to significant financial losses for investors [3][5]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi is encouraging investors who suffered losses exceeding $75,000 in Organon between October 31, 2024, and April 30, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Organon, with a deadline of July 22, 2025, for investors to seek the role of lead plaintiff [3]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4]. Group 2: Financial Misrepresentation - Defendants provided misleading information about Organon's commitment to regular quarterly dividends, claiming it was a "1 capital allocation priority" while concealing the prioritization of debt reduction following the acquisition of Dermavant [5]. - The misleading statements resulted in a 70% decrease in the regular quarterly dividend, causing shareholders to purchase securities at artificially inflated prices [5]. Group 3: Market Reaction - Following the revelations about Organon's financial practices, the company's stock price dropped from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025, marking a decline of over 27% in just one day [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GoHealth, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Investigation and Class Action - Shareholders who purchased GoHealth securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to GoHealth [2]. Group 2: Allegations and Stock Impact - The U.S. Department of Justice announced charges against GoHealth, alleging that from 2016 to 2021, the company was involved in illegal kickbacks totaling hundreds of millions of dollars to brokers for enrollments in Medicare Advantage plans [3]. - Following the announcement of these charges, GoHealth's stock price dropped by 10.3% on May 1, 2025, and an additional 6.7% on May 2, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered over $438 million for investors in 2019 alone [4].

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA). Shareholders who purchased shares of IBTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ibotta-loss-submission-form/?id=149360&from=3 CLASS PERIOD: This lawsuit is on behalf of ...

NEW YORK, May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI).Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=148814&from=4CLASS PERIOD: March 13, 2023 to March 11, 2025 ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Ibotta To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Ibotta pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Ibotta's April 18, 2024 initial public offering (the "IPO") and would like to discuss your legal rights, call Faruqi ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avis Budget Group, Inc. due to significant financial losses attributed to misleading statements and a flawed fleet rotation strategy [3][5]. Group 1: Financial Performance - Avis Budget reported a loss of $1.96 billion, or $55.66 per share, for Q4 2024, compared to a profit of $259 million, or $7.10 per share, in the same period the previous year [6]. - The loss was primarily due to a one-time non-cash impairment of $2.3 billion and additional non-cash charges of $180 million resulting from an accelerated fleet rotation strategy [6]. Group 2: Legal Implications - A federal securities class action has been filed against Avis, with a deadline of June 24, 2025, for investors to seek the role of lead plaintiff [3][8]. - The complaint alleges that Avis and its executives violated federal securities laws by making false or misleading statements regarding the company's financial health and fleet management strategy [5]. Group 3: Management Changes - CEO Joseph A. Ferraro will transition to a Board Advisor role effective June 30, 2025, with Brian Choi, the Chief Transformation Officer, taking over as CEO on July 1, 2025 [7]. - Following the announcement of these changes, Avis Budget's stock price fell by $6.12 per share, or 6.82%, closing at $83.59 per share [7]. Group 4: Investor Outreach - Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 in Avis to contact them for discussions regarding their legal rights [1][9]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Avis' conduct [9].